rs146180431
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4BP6_Very_StrongBS2
The NM_003334.4(UBA1):āc.965A>Gā(p.Lys322Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000291 in 1,208,857 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 121 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00015 ( 0 hom., 1 hem., cov: 24)
Exomes š: 0.00031 ( 0 hom. 120 hem. )
Consequence
UBA1
NM_003334.4 missense
NM_003334.4 missense
Scores
4
6
7
Clinical Significance
Conservation
PhyloP100: 7.38
Genes affected
UBA1 (HGNC:12469): (ubiquitin like modifier activating enzyme 1) The protein encoded by this gene catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation. This gene complements an X-linked mouse temperature-sensitive defect in DNA synthesis, and thus may function in DNA repair. It is part of a gene cluster on chromosome Xp11.23. Alternatively spliced transcript variants that encode the same protein have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), UBA1. . Gene score misZ 3.4752 (greater than the threshold 3.09). GenCC has associacion of gene with infantile-onset X-linked spinal muscular atrophy, inflammatory disease.
BP4
Computational evidence support a benign effect (MetaRNN=0.29098848).
BP6
Variant X-47202413-A-G is Benign according to our data. Variant chrX-47202413-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 465037.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-47202413-A-G is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAdExome4 at 120 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBA1 | NM_003334.4 | c.965A>G | p.Lys322Arg | missense_variant | 10/26 | ENST00000335972.11 | NP_003325.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBA1 | ENST00000335972.11 | c.965A>G | p.Lys322Arg | missense_variant | 10/26 | 1 | NM_003334.4 | ENSP00000338413.6 | ||
UBA1 | ENST00000377351.8 | c.965A>G | p.Lys322Arg | missense_variant | 10/26 | 1 | ENSP00000366568.4 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 17AN: 112164Hom.: 0 Cov.: 24 AF XY: 0.0000291 AC XY: 1AN XY: 34330
GnomAD3 genomes
AF:
AC:
17
AN:
112164
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34330
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000219 AC: 39AN: 178388Hom.: 0 AF XY: 0.000221 AC XY: 14AN XY: 63224
GnomAD3 exomes
AF:
AC:
39
AN:
178388
Hom.:
AF XY:
AC XY:
14
AN XY:
63224
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000305 AC: 335AN: 1096693Hom.: 0 Cov.: 33 AF XY: 0.000331 AC XY: 120AN XY: 362119
GnomAD4 exome
AF:
AC:
335
AN:
1096693
Hom.:
Cov.:
33
AF XY:
AC XY:
120
AN XY:
362119
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000152 AC: 17AN: 112164Hom.: 0 Cov.: 24 AF XY: 0.0000291 AC XY: 1AN XY: 34330
GnomAD4 genome
AF:
AC:
17
AN:
112164
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
31
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 12, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Infantile-onset X-linked spinal muscular atrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 04, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MVP
MPC
1.1
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at